Form 8-K - Current report:
SEC Accession No. 0000950170-25-095296
Filing Date
2025-07-11
Accepted
2025-07-11 16:15:28
Documents
10
Period of Report
2025-07-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K ck0001991792-20250707.htm   iXBRL 8-K 48774
  Complete submission text file 0000950170-25-095296.txt   162258

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ck0001991792-20250707.xsd EX-101.SCH 26974
12 EXTRACTED XBRL INSTANCE DOCUMENT ck0001991792-20250707_htm.xml XML 5113
Mailing Address 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618
Business Address 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618 (949) 419-6203
CG Oncology, Inc. (Filer) CIK: 0001991792 (see all company filings)

EIN.: 371611499 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41925 | Film No.: 251119159
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)